年龄相关性黄斑变性合并1型黄斑新生血管的吲哚菁绿血管造影与中心性浆液性脉络膜视网膜病变揭示不同疾病机制
回顾性研究纳入2012至2020年83只眼(中心性浆液性脉络膜视网膜病变35只、年龄相关性黄斑变性48只)的1型黄斑新生血管,评估晚期吲哚菁绿血管造影高荧光斑块的发生率及预后价值。中心性浆液性脉络膜视网膜病变组晚期高荧光斑块发生率低于年龄相关性黄斑变性组(31.4% vs 77.1%,P<0.001),多变量分析显示年龄相关性黄斑变性与晚期高荧光斑块存在相关(P<0.001)。两组对抗血管内皮生长因子治疗的反应无显著差异。
要点
- 中心性浆液性脉络膜视网膜病变组1型黄斑新生血管的晚期高荧光斑块发生率低于年龄相关性黄斑变性组(31.4% vs 77.1%,P<0.001)。
- 多变量分析显示年龄相关性黄斑变性与晚期高荧光斑块存在相关(P<0.001)。
- 两组对抗血管内皮生长因子治疗的反应无显著差异。
核心结论
- 中心性浆液性脉络膜视网膜病变眼中1型黄斑新生血管的大分子渗漏并在视网膜色素上皮和/或间质内蓄积(表现为晚期高荧光斑块)较年龄相关性黄斑变性眼少见。
- 晚期吲哚菁绿血管造影成像有助于了解染料代谢及新生血管膜周围环境。
研究设计与样本
- 回顾性研究纳入2012至2020年年龄相关性黄斑变性和中心性浆液性脉络膜视网膜病变的1型黄斑新生血管眼,共83只眼(中心性浆液性脉络膜视网膜病变35只、年龄相关性黄斑变性48只)。
- 纳入标准为具有晚期吲哚菁绿血管造影图像(>20分钟)且光学相干断层扫描血管成像(OCTA)上黄斑新生血管清晰可见。
- 记录基线和每月一次抗血管内皮生长因子注射三次后的光学相干断层扫描定量与定性参数及最佳矫正视力。
主要发现
- 中心性浆液性脉络膜视网膜病变组患者年龄显著小于年龄相关性黄斑变性组(61.3 ± 10.4岁 vs 80.2 ± 6.8岁,P < 0.001)。
- 中心性浆液性脉络膜视网膜病变组男性比例高于年龄相关性黄斑变性组(68.6% vs 35.4%,P = 0.003)。
- 中心性浆液性脉络膜视网膜病变组脉络膜厚度大于年龄相关性黄斑变性组(379 ± 93.3 µm vs 204.2 ± 93.2 µm,P < 0.001)。
- 中心性浆液性脉络膜视网膜病变组1型黄斑新生血管的晚期高荧光斑块发生率低于年龄相关性黄斑变性组(31.4% vs 77.1%,P < 0.001)。
- 有晚期高荧光斑块的患者基线视力低于无晚期高荧光斑块者(0.37 ± 0.22 vs 0.27 ± 0.28 logMAR,P = 0.03)。
临床怎么用
- 作者认为晚期吲哚菁绿血管造影成像有助于了解染料代谢及新生血管膜周围环境。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the rate of late phase hyperfluorescent plaque (LPHP) in Type 1 macular neovascularization (MNV) in central serous chorioretinopathy (CSCR) and age-related macular degeneration (AMD) and to evaluate its prognostic value. METHODS: Retrospective study including Type 1 MNV in AMD and CSCR, from 2012 to 2020. Eyes with a late indocyanine green angiography image (>20 minutes) and clear visualization of MNV on optical coherence tomography angiography (OCTA) were included. Quantitative and qualitative parameters on optical coherence tomography and best-corrected visual acuity were recorded at baseline and after three monthly antivascular endothelial growth factor injections. RESULTS: Eighty-three eyes were included, 35 with CSCR and 48 with AMD. Patients in the CSCR group were significantly younger than in the AMD group (61.3 ± 10.4 vs. 80.2 ± 6.8 years, respectively, P < 0.001), predominantly male (68.6% CSCR vs. 35.4% AMD; P = 0.003), and with a thicker choroid (379 ± 93.3 µ m vs. 204.2 ± 93.2 µ m; P < 0.001). Type 1 MNV in CSCR showed fewer LPHP compared with AMD (31.4% vs. 77.1%; P < 0.001). The baseline visual acuity was lower in patients with LPHP (0.37 ± 0.22 vs. 0.27 ± 0.28 logarithm of the minimum angle of resolution, P = 0.03). On multivariate analysis, AMD was associated with the presence of LPHP ( P < 0.001). No significant difference in the response to antivascular endothelial growth factor was observed. CONCLUSION: Leakage of macromolecules from MNV and accumulation in the retinal pigment epithelium and/or in the stroma imaged by the LPHP is less common in eyes with Type 1 MNV in CSCR than in AMD. Late phase indocyanine green angiography imaging offers an insight into the metabolism of the dye and the environment surrounding the neovascular membrane.
引用
- Zola M, Bousquet E, Favard C, et al. INDOCYANINE GREEN ANGIOGRAPHY OF TYPE 1 MACULAR NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION AND CENTRAL SEROUS CHORIORETINOPATHY REVEALS DIFFERENT DISEASE MECHANISMS. Retina. 2023. PMID: 37155967. doi:10.1097/IAE.0000000000003833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。